Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02255123 · ClinicalTrials.gov registry record

Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study

A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
178
Enrollment target

NCT02255123 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 178 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02255123 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
178 participants
Enrollment target

Study Summary

This study is a multicenter, non-randomized, retrospective study to collect long term (4 years post-transplant) clinical outcome data on subjects previously enrolled in the CTOT-05 study (NCT00466804) to evaluate participant and graft survival.

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2014-10
Est. Completion 2015-06

What the Registry Record Tells You About NCT02255123

The ClinicalTrials.gov registry entry for NCT02255123 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02255123 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02255123 about?

NCT02255123 is a clinical study titled "Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study". This study is a multicenter, non-randomized, retrospective study to collect long term (4 years post-transplant) clinical outcome data on subjects previously enrolled in the CTOT-05 study (NCT00466804) to evaluate participant and graft survival.

What is the current status of trial NCT02255123?

This trial is currently completed. The enrollment target is 178 participants. The study started on 2014-10. Estimated completion is 2015-06.

Who is sponsoring clinical trial NCT02255123?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.